Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents
Open accessThe DOI matches its Crossref record; 75 of the 78 references it cites were found in a registry or an index; 36 of the 43 sources its claims cite were checked for support.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Hyperandrogenism, hyperinsulinism and insulin resistance (IR) are the main drivers of clinical, metabolic and reproductive phenotypes of PCOS. In adolescence, the cornerstones of PCOS treatment are lifestyle and dietary interventions. In particular, the quality and quantity of carbohydrates introduced with the diet play a crucial role in the benefits of diet on PCOS. Recently, the ketogenic diet (KD) has attracted significant interest for the treatment of IR and for the control of carbohydrate metabolism, which has proven to be beneficial for several dysmetabolic conditions, including PCOS. The goal of the KD is to induce a fasting-like metabolism with production of chetonic bodies. Ketosis is a good regulator of calorie intake and mimics the starvation effect in the body, leading to body weight control and consequent metabolism. Additionally, during ketogenesis, insulin receptor sensitivity is also promoted. We proposed a broad overview of the available literature regarding KD indications and considered its metabolic benefits useful for improving PCOS management. The reported data support that a low-calorie ketogenic diet (LCKD) plays a positive role as a regulator of control weight, IR, glucose and lipid homeostasis and hormonal profile. Unfortunately, the evidence concerning the benefits of the very LCKD in adolescents with PCOS and excessive body weight is still numerically scarce. Further studies are necessary to understand whether these effects are due to weight loss or to the nutritional characteristics of this diet. Considering the long-term consequences of PCOS, it is crucial to detect the prospects of nutritional interventions to protect fertility, starting in adolescence.
Overview
CoChat Summary
## TL;DR
This is a narrative review arguing that low-calorie ketogenic diets may help manage polycystic ovary syndrome (PCOS), including in adolescents, by improving weight, insulin resistance, glucose/lipid homeostasis, and hormonal profiles. The authors conclude that adolescent-specific evidence is still scarce and that more studies are needed to separate the effects of ketosis from those of weight loss.
## Key findings
- The review cites evidence that in PCOS, low-carbohydrate dietary patterns can improve outcomes: a 2020 meta-analysis found a greater reduction in insulin resistance with low-carbohydrate than high-carbohydrate diets.
- In a randomized controlled trial of 72 overweight women with PCOS aged 16–45 years, a 12-week Mediterranean diet plus low-carbohydrate model improved anthropometric and endocrine parameters.
- A pilot study of 11 women with PCOS following a low-calorie ketogenic diet for 24 weeks reported that the 5 women who completed the study had significant reductions in body weight, free testosterone, LH/FSH ratio, fasting insulin, and symptoms; 2 conceived after 4 weeks.
- Across the studies discussed, the authors report short-term improvements in weight and fat mass loss, insulin resistance, glucose and lipid homeostasis, androgen levels, LH/FSH ratio, and SHBG.
## Methods
- Narrative review, described as a non-systematic summation and analysis of the literature on low-calorie ketogenic diets in PCOS, with a focus on adolescents.
- Searched MEDLINE/PubMed, Scopus, and Web of Science for the last 15 years, limited to English-language human studies; excluded in vitro, animal, elderly, epilepsy, and malnutrition studies.
- Screening flow: 201 papers identified, 69 titles/abstracts assessed, 41 full texts reviewed; disagreements were resolved by a fourth author.
## Limitations
- The paper explicitly states that evidence for the benefits of VLCKD in adolescents with PCOS and excessive body weight is “numerically scarce” and that clinical trials in adolescents are lacking.
- The authors state that further studies are needed to determine whether observed effects are due to weight loss or to the diet’s nutritional characteristics.
- Evident from the text: because this is a narrative, non-systematic review, the paper does not present a pooled effect estimate or a formal risk-of-bias assessment.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
24 Valid · 0 Not valid · 4 Not checked · 4 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Additionally, during ketogenesis, insulin receptor sensitivity is also promoted.”
- Also stated in: § 1. Introduction · plain
“During ketogenesis, insulin receptor sensitivity is also promoted; therefore, KD can modulate insulin fluctuation and secretion which are also caused by decreased carbohydrate intake, ultimately leading to improved insulin sensitivity [8,9,10].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > Abstract
What the sources say
- Partly supportedcites [8] Zhou, C., Wang, M., Liang, J., He, G., and Chen, N. (2022). Ketogenic Diet Benefits to Weight Loss, Glycemic Control, and Lipid Profiles in Overweight Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trails. Int. J. Environ. Res. Public. Health, 19. sourceExperimental — accuracy not yet measured
The Discussion (section 4; page not provided) says diet-induced mild ketosis might improve peripheral insulin sensitivity, which supports the general idea but is more tentative than the claim. It does not establish increased insulin receptor sensitivity specifically. The Results (section 3.5; page not provided) report no significant difference in HOMA-IR between diet groups. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [9] Cox, 2019, Ketogenic Diets Potentially Reverse Type II Diabetes and Ameliorate Clinical Depression: A Case Study, Diabetes Metab. Syndr. source
- Partly supportedcites [10] Goday, 2016, Short-Term Safety, Tolerability and Efficacy of a Very Low-Calorie-Ketogenic Diet Interventional Weight Loss Program versus Hypocaloric Diet in Patients with Type 2 Diabetes Mellitus, Nutr. Diabetes sourceExperimental — accuracy not yet measured
The Results (Diet-induced changes in efficacy parameters; page unavailable) report a lower HOMA-IR in the very-low-calorie ketogenic diet group than in the comparison group, and the Discussion interprets this as improved insulin sensitivity. The paper does not measure insulin receptor sensitivity or establish that ketogenesis caused the improvement; the Discussion says the study cannot separate the effects of weight loss from carbohydrate restriction. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In patients with excessive weight, achievable goals, such as 5% to 10% weight loss within six months, led to significant clinical improvements [2].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > 5. Ketogenic Diet and Polycystic Ovary Syndrome
What the sources say
- Partly supportedcites [2] Teede, 2018, Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, Fertil. Steril. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) prioritizes lifestyle intervention to prevent or manage excess weight in people with PCOS. Our copy does not state a goal of 5%–10% weight loss within six months or report that achieving it led to significant clinical improvements; those specifics are not supported. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The Mediterranean diet (MD) is a dietary pattern rich in complex carbohydrates and fiber, and high in monounsaturated fat, that is closely associated with an improvement in low-grade chronic inflammation, IR, and hormonal derangements in PCOS [4].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > 1. Introduction
What the sources say
- Partly supportedcites [4] Calcaterra, V., Verduci, E., Cena, H., Magenes, V.C., Todisco, C.F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., and Di Profio, E. (2021). Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients, 13. sourceExperimental — accuracy not yet measured
Section 6.3 associates the Mediterranean diet with improved insulin resistance in people with PCOS and excess body weight, and with reduced inflammation. It does not directly attribute improvement in hormonal derangements to the Mediterranean diet; its discussion of ovulatory cycles and androgen levels concerns low-glycemic-index diets more generally. Page numbers are unavailable in our copy. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This is also supported by the randomized controlled clinical trial conducted by Mei et al. in 2022 on a sample of 72 overweight women with PCOS (aged between 16 and 45), who followed a MD combined with a low-carbohydrate (LC) dietary model for 12 weeks, observing an improvement in anthropometric and endocrine parameters [65,66].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > 5. Ketogenic Diet and Polycystic Ovary Syndrome
What the sources say
- Partly supportedcites [65] Mei, 2022, Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients, Front. Nutr. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Could not verifycites [66] Paoli, 2013, Beyond Weight Loss: A Review of the Therapeutic Uses of Very-Low-Carbohydrate (Ketogenic) Diets, Eur. J. Clin. Nutr. sourceExperimental — accuracy not yet measured
The ‘Emerging evidence’ section discusses only preliminary evidence for very-low-carbohydrate ketogenic diets in PCOS; it does not describe the trial in the claim. Searches for Mei et al., the 72 participants, the 12-week Mediterranean–low-carbohydrate diet, and its outcomes found no passage in our copy addressing that trial. Page numbers were unavailable. (LLM, conf=0.78)
plainstates a causen = 72- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Hyperandrogenism, hyperinsulinism and insulin resistance (IR) are the main drivers of clinical, metabolic and reproductive phenotypes of PCOS.”
- Also stated in: § 1. Introduction · hedged
“The pathogenesis of PCOS remains not fully elucidated, and it is thought to be led by both exogenous and endogenous factors, with hyperandrogenism, hyperinsulinism and insulin resistance (IR) being the main drivers of clinical, metabolic and reproductive phenotypes [3].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > Abstract
What the sources say
- Partly supportedcites [3] Sadeghi, H.M., Adeli, I., Calina, D., Docea, A.O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., and Abdollahi, M. (2022). Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int. J. Mol. Sci., 23. sourceExperimental — accuracy not yet measured
Section 4.2 describes how insulin resistance, hyperinsulinemia and hyperandrogenism contribute to metabolic changes and disrupted follicle growth and ovulation. But the Introduction says PCOS has an incompletely understood, multifactorial etiology; the review does not establish these three as the main drivers of all clinical, metabolic and reproductive phenotypes. Page numbers are unavailable in our copy. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · hedged
12 more claims · 9 with their cited sources checked
Create a free account to see all 32 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 13
- Probably not a substantial claim. 4
- The quote only partly states this claim. 1
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.004 · Cited by 1,325
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · cited 2×
“It is important to underline that cut-off values were lower than those applied to adult populations, and that the clinical hyperandrogenism score was lower in PCOS adolescents than in adults, according to what has been previously reported in the literature regarding the longer time needed for the pilosebaceous glands…”
BackgroundResultBeyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Endocrine-disrupting chemicals: Implications for human health
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30129-7 · Cited by 797
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676 · cited 1×
“In the first phase, patients follow a VLCKD (around 600 and 800 kcal/day) or a LCKD (>800 kcal/day and <total energy expenditure) (50); the latter is preferred to meet needs and avoid deficiencies in adolescents with PCOS [56,59].”
BackgroundHeritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647 · cited 1×
“genes were involved in PCOS phenotype traits, such as obesity, insulin resistance, impaired ovulatory function, gonadotropin level regulation and infertility [17].”
Background
Cited by
Calcaterra, V., Magenes, V. C., Massini, G., De Sanctis, L., Fabiano, V., & Zuccotti, G. (2024) · Nutrients · doi:10.3390/nu16070938 · Cited by 35
“…indicated an imbalance Indeed, IR was recently shown to have a prevalence of 70–80% in women with PCOS who are overweight and 30% in lean women [18,20]. speci fi c bacterial species, such as Bacteroidetes and Firmicutes, in women with PCOS, which can impact the production of short-chain fa tt…”
BackgroundInfluentialSelf-citationEffects of ketogenic diets on polycystic ovary syndrome: a systematic review and meta-analysis
Cannarella, R., Rubulotta, M., Leonardi, A., Crafa, A., Calvo, A., Barbagallo, F., Vignera, S. L., & Calogero, A. E. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01411-1 · Cited by 23
“These factors also increase cardiovascular risk [29, 32].”
Johnson, C., Garipoğlu, G., Jeanes, Y., Frontino, G., & Costabile, A. (2025) · Current Nutrition Reports · doi:10.1007/s13668-024-00601-4 · Cited by 27
Clemente‐Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Sepulveda, R. A. Y., Rubio-Zarapuz, A., Martín-Rodríguez, A., Navarro-Jiménez, E., & Tornero-Aguilera, J. F. (2025) · Metabolites · doi:10.3390/metabo15070453 · Cited by 21
Wu, J., & Jacobson-Dickman, E. E. (2025) · Nutrition · doi:10.1016/j.nut.2025.113021 · Cited by 6
Metadata
- Authors
- Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G.
- Affiliations
- University of Pavia (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
- University of Milan (IT)
- Corresponding author
- Cena, Hellas
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-08-15
- Volume
- 15
- Issue
- 16
- Pages
- 3582
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10459579
- OpenAlex
- W4385839940
- Semantic Scholar
- 19b1163708dd0b442d2f35c32d5476d26d88dfd9
- Cited by
- 27
- References
- 78
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 8
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Union-NextGenerationEU (PE00000003)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- polycystic ovary syndrome, ketogenic diet, adolescents, insulin resistance, weight loss, carbohydrate metabolism, insulin sensitivity, hyperinsulinism, hyperandrogenism, lipid homeostasis, glucose homeostasis, fertility preservation, dietary intervention
- MeSH terms
- Body Weight, Energy Intake, Female, Humans, Hyperinsulinism, Insulin Resistance, Polycystic Ovary Syndrome, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents. https://app.cochat.ai/papers/10.3390/nu15163582
- The paper
- Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G. (2023). Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents. Nutrients. https://doi.org/10.3390/nu15163582
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
